These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 19031938)

  • 21. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
    Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
    Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions.
    Lamerz R; Stoetzer OJ; Mezger J; Brandt A; Darsow M; Wilmanns W
    Anticancer Res; 1999; 19(4A):2421-5. PubMed ID: 10470169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions.
    Hsieh TC; Huang WW; Lai CL; Tsao SM; Su CC
    Cancer Cytopathol; 2013 Sep; 121(9):483-8. PubMed ID: 23408492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical value of tumor supplied group of factor combined with CEA in diagnosing tuberculosis pleural effusion and malignant pleural effusion].
    Li YP; Hu CP; Yang HZ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):608-10. PubMed ID: 15804072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of CEA and CA19-9 in identifying pleural effusions caused by specific malignancies.
    Hackbarth JS; Murata K; Reilly WM; Algeciras-Schimnich A
    Clin Biochem; 2010 Sep; 43(13-14):1051-5. PubMed ID: 20529669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CEA and CA 549 in serum and pleural fluid of patients with pleural effusion.
    Hernández L; Espasa A; Fernández C; Candela A; Martín C; Romero S
    Lung Cancer; 2002 Apr; 36(1):83-9. PubMed ID: 11891038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic efficiency of serum lipid-bound sialic acid level in malignant pleural effusions].
    Bektemür G; Ozer F; Kanat F; Imecik O
    Tuberk Toraks; 2003; 51(3):265-70. PubMed ID: 15143404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostic usefulness of neurospecific enolase determination in pleural fluid].
    Romero S; Izquierdo M; Mauri M; Martín C; Almenar MV; García R; Padilla I
    Med Clin (Barc); 1989 Nov; 93(15):568-71. PubMed ID: 2622261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
    Zhou WB; Bai M; Jin Y
    Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
    Chierakul N; Kanitsap A; Chaiprasert A; Viriyataveekul R
    Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1.
    Son SM; Han HS; An JY; Choe KH; Lee KM; Lee KH; Kim SS; Lee YM; Lee HC; Song HG; Lee OJ
    Pathology; 2015 Feb; 47(2):123-9. PubMed ID: 25551300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
    Toumbis M; Chondros K; Ferderigos AS; Daganou M; Dema A; Dalamaga A; Kakari S; Stringou E
    Anticancer Res; 1992; 12(4):1267-70. PubMed ID: 1503419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion.
    Riantawan P; Sangsayan P; Bangpattanasiri K; Rojanaraweewong P
    Respiration; 2000; 67(1):24-9. PubMed ID: 10705258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of combined use of serum tumour markers and nuclear magnetic spectroscopy of plasma in the detection of pancreatic cancer among patients with jaundice or cholestasis: results from a prospective study.
    Pasanen PA; Kauppinen R; Eskelinen M; Partanen K; Pikkarainen P; Alhava E
    Anticancer Res; 1993; 13(3):763-8. PubMed ID: 8317910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of the determination of CA 15-3 in the diagnosis of malignant pleural effusion].
    Romero S; Hernández L; Salar A; García-Sevila R; Espasa MA; Martín-Serrano C
    Rev Clin Esp; 1992 Apr; 190(7):339-43. PubMed ID: 1620918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions.
    Romero S; Fernández C; Arriero JM; Espasa A; Candela A; Martín C; Sánchez-Payá J
    Eur Respir J; 1996 Jan; 9(1):17-23. PubMed ID: 8834328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
    Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
    Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
    Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
    Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions.
    Wu GP; Zhang SS; Fang CQ; Liu SL; Wang EH
    Cytopathology; 2008 Aug; 19(4):212-7. PubMed ID: 18699986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.